Personal information

Emails & domains

Verified email domains

Websites & social links

MONASH UNIVERSITY profile page

Other IDs

Scopus Author ID: 17136069200

Activities

Collapse all

Employment (1)

MONASH UNIVERSITY: Clayton, AU

Employment
Source: check_circle
Monash University

Works (50 of 63)

Items per page:
Page 1 of 2

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma

The Lancet Haematology
2019-03-01 | Journal article | Author
DOI: 10.1016/S2352-3026(19)30013-4
SOURCE-WORK-ID:

f95e4290-d936-4a01-a2b8-95b3ec011d7c

EID:

2-s2.0-85061927815
Contributors: Joshua ML Casan; Alison Barraclough; Jake Shortt; Eliza A. Hawkes
Source: check_circle
Monash University

A comprehensive protocol resource for performing pooled shRNA and CRISPR screens

Methods in Molecular Biology
2018 | Book chapter | Author
Part of DOI: 10.1007/978-1-4939-7568-6_17
SOURCE-WORK-ID:

2d929138-1b73-472a-9a8b-e38ee3f9dabc

EID:

2-s2.0-85040695335

Part of ISBN: 9781493975686
Part of ISBN: 9781493975679
Contributors: Leonie A. Cluse; Iva Nikolic; Deborah Knight; Piyush B. Madhamshettiwar; Jennii Luu; Karla J. Cowley; Timothy Semple; Gisela Mir Arnau; Jake Shortt; Ricky W. Johnstone et al.
Source: check_circle
Monash University

Tumor Lysis Syndrome

Textbook of Palliative Care
2018 | Book chapter | Author
Part of DOI: 10.1007/978-3-319-31738-0_76-1
SOURCE-WORK-ID:

3bd789dd-c677-41e8-994d-a18b8e243465

Part of ISBN: 9783319317380
Contributors: Gareth Peter Gregory; Jake Shortt
Source: check_circle
Monash University

Adaptive reprogramming of NK cells in X-Linked lymphoproliferative syndrome

Blood
2018-02-08 | Journal article | Author
DOI: 10.1182/blood-2017-08-803668
SOURCE-WORK-ID:

4048ad54-c4e4-46b6-a0be-6085ef18b672

EID:

2-s2.0-85041909588

WOSUID:

000424652800013
Contributors: Stephen Opat; Anna C. Hearps; Kevin Thia; Agnes Yuen; Ben Rogers; Mkunde Chachage; Gregory Thomas Charles Moore; Jake Shortt; Georgina Ryland; Piers Blombery et al.
Source: check_circle
Monash University

Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase

British Journal of Haematology
2017-10 | Journal article | Author
DOI: 10.1111/bjh.14829
SOURCE-WORK-ID:

c94dc0db-8803-4cc3-aa24-833916df2372

EID:

2-s2.0-85023209621

WOSUID:

000412835500006
Contributors: Timothy P Hughes; Eduardo Munhoz; Marco Aurelio Salvino; Tee Chuan Ong; Alaa Elhaddad; Jake Shortt; Hang Quach; Carolina Pavlovsky; Vernon J. Louw; Lee-Yung Shih et al.
Source: check_circle
Monash University

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Blood Advances
2017-05-23 | Journal article | Author
DOI:

10.1182/ bloodadvances.2016003889

SOURCE-WORK-ID:

da7aa766-e567-4edf-b86c-fc81b096801d
Contributors: Lucy C. Fox; Katherine D. Cummins; Ben Costello; David Yeung; Rebecca Cleary; Cecily Forsyth; Maciek Tatarczuch; Kate Burbury; Olga Motorna; Jake Shortt et al.
Source: check_circle
Monash University

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene

Nature Communications
2017-03-06 | Journal article | Author
DOI: 10.1038/ncomms14581
SOURCE-WORK-ID:

c3ff3c64-0a3c-4fd7-904a-9b5d925183c3

EID:

2-s2.0-85014614477
Contributors: Marcus Lefebure; Richard W. Tothill; Elizabeth Kruse; Edwin D. Hawkins; Jake Shortt; Geoffrey M. Matthews; Gareth Peter Gregory; Benjamin P. Martin; Madison J. Kelly; Izabela Todorovski et al.
Source: check_circle
Monash University

High rates of potentially infectious exposures between immunocompromised patients and their companion animals

Internal Medicine Journal
2017-03-01 | Journal article | Author
DOI: 10.1111/imj.13361
SOURCE-WORK-ID:

663f14ce-cf60-4b50-a774-35fe5b54da96

EID:

2-s2.0-85014340494
Contributors: Greta A. Gurry; Veronique Campion; Chamath Premawardena; Ian John Woolley; Jake Shortt; Donald K. Bowden; Zane Kaplan; Claire Dendle
Source: check_circle
Monash University

BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

Cell Reports
2017-02-28 | Journal article | Author
DOI: 10.1016/j.celrep.2017.02.011
SOURCE-WORK-ID:

533bfa2f-99eb-440d-a13a-42a6246ebd31

EID:

2-s2.0-85014119593
Contributors: Simon J. Hogg; Stephin J. Vervoort; Sumit Deswal; Christopher J. Ott; Jason Li; Leonie A. Cluse; Paul A. Beavis; Phillip K. Darcy; Benjamin P. Martin; Andrew Spencer et al.
Source: check_circle
Monash University

Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Cancer Discovery
2016 | Journal article | Author
DOI: 10.1158/2159-8290.CD-14-0673
SOURCE-WORK-ID:

8376ede5-3bd1-4f67-9492-cce2db8948b1

EID:

2-s2.0-84954064847
Contributors: Jennifer R Devlin; Katherine M Hannan; Nadine Hein; Carleen M Cullinane; Eric P Kusnadi; Pui Yee Ng; Amee J George; Jake Shortt; Megan J Bywater; Gretchen Poortinga et al.
Source: check_circle
Monash University

Intramuscular transplantation improves engraftment rates for esophageal patient-derived tumor xenografts

Annals of Surgical Oncology
2016 | Journal article | Author
DOI: 10.1245/s10434-015-4425-3
SOURCE-WORK-ID:

8e2bfe2a-85b6-4523-a2ab-d8f54c7a39a9

EID:

2-s2.0-84952628265

WOSUID:

000367458100045
Contributors: Matthew Read; David Shi Hao Liu; Cuong Phu Duong; Carleen M Cullinane; William K Murray; Christina M Fennell; Jake Shortt; David A Westerman; Paul Robert Burton; Nicholas J Clemons et al.
Source: check_circle
Monash University

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

Blood Advances
2016-11-22 | Journal article | Author
DOI: 10.1182/bloodadvances.2016001412
SOURCE-WORK-ID:

a4eb7701-e172-484e-ba60-94423acf2873

WOSUID:

000410645500006
Contributors: Sumita Ratnasingam; Patricia A. Walker; Huy Tran; Zane S. Kaplan; James McFadyen; Huyen Tran; Tse-Chieh Teh; Shaun Fleming; John V. Catalano; Sanjeev D. Chunilal et al.
Source: check_circle
Monash University

Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ

Bioorganic and Medicinal Chemistry Letters
2016-10-01 | Journal article | Author
DOI: 10.1016/j.bmcl.2016.08.028
SOURCE-WORK-ID:

9376ba94-7362-4f9d-8389-ad9177a61d63

EID:

2-s2.0-84985931059
Contributors: Michelle S. Miller; Simon J. Mountford; Jo-Anne Pinson; Zhaohua Zheng; Marco Künzli; Vanit Patel; Simon J. Hogg; Jake Shortt; Ian G. Jennings; Philip Thompson
Source: check_circle
Monash University

BET inhibition induces apoptosis in aggressive B-cell lymphoma via epigenetic regulation of BCL-2 family members

Molecular Cancer Therapeutics
2016-09-01 | Journal article | Author
DOI: 10.1158/1535-7163.MCT-15-0924
SOURCE-WORK-ID:

dcb09153-321d-4ae6-9b2b-d51fa63c4de5

EID:

2-s2.0-84990935124
Contributors: Simon J. Hogg; Andrea Newbold; Stephin J. Vervoort; Leonie A. Cluse; Benjamin P. Martin; Gareth Peter Gregory; Marcus Lefebure; Eva Vidacs; Richard W. Tothill; James E. Bradner et al.
Source: check_circle
Monash University

Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model

International Journal of Cancer
2016-07-01 | Journal article | Author
DOI: 10.1002/ijc.30056
SOURCE-WORK-ID:

6ff22e11-7a1e-43a3-ad0d-c37d7033a96a

EID:

2-s2.0-84960401159
Contributors: Kelly Waldeck; Carleen Cullinane; Kerry Ardley; Jake Shortt; Ben Martin; Richard W. Tothill; Jason Li; Ricky W. Johnstone; Grant A. McArthur; Rodney J. Hicks et al.
Source: check_circle
Monash University

The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock

Oncogenesis
2016-04-04 | Journal article | Author
DOI: 10.1038/oncsis.2016.26
SOURCE-WORK-ID:

996aec15-897e-48b8-8c70-170e23359deb

EID:

2-s2.0-84962740284

WOSUID:

000375278100005
Contributors: A. C. West; Benjamin P Martin; D. A. Andrews; S. J. Hogg; A. Banerjee; G. Grigoriadis; R. W. Johnstone; Jake Shortt
Source: check_circle
Monash University

Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma

Annals of Hematology
2016-03-01 | Journal article | Author
DOI: 10.1007/s00277-016-2601-6
SOURCE-WORK-ID:

6e8b8ac1-ee65-4edd-8c33-760259e8d2ec

EID:

2-s2.0-84959509739
Contributors: Pasquale L. Fedele; Gareth Peter Gregory; Michael Gilbertson; Jake Shortt; Beena Kumar; Stephen Opat; George Grigoriadis
Source: check_circle
Monash University

The CDK9 inhibitor dinaciclib exerts potent apoptotic and antitumor effects in preclinical models of MLL-rearranged acute myeloid Leukemia

Cancer Research
2016-03-01 | Journal article | Author
DOI: 10.1158/0008-5472.CAN-15-1070
SOURCE-WORK-ID:

edb72377-b079-4e8a-9bc2-3a19944c0fda

EID:

2-s2.0-84961736635
Contributors: Adele Baker; Gareth Peter Gregory; Inge Verbrugge; Lev Kats; Joshua J. Hilton; Eva Vidacs; Erwin M. Lee; Richard B. Lock; Johannes Zuber; Jake Shortt et al.
Source: check_circle
Monash University

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo

Leukemia
2015 | Journal article | Author
DOI: 10.1038/leu.2015.10
SOURCE-WORK-ID:

b35b1c03-9a65-448d-8b7a-c1dc8c14c837

EID:

2-s2.0-84930571469
Contributors: Gareth Peter Gregory; S J Hogg; L M Kats; E Vidacs; A J Baker; O Gilan; M Lefebure; B P Martin; M A Dawson; R W Johnstone et al.
Source: check_circle
Monash University

Letter to the editor, BET inhibitor JQ1 blocks inflammation and bone destruction

Journal of Dental Research
2015 | Journal article | Author
DOI: 10.1177/0022034514557673
SOURCE-WORK-ID:

037dee10-7af7-4e8e-919e-269e6e033f4b

EID:

2-s2.0-84919467744
Contributors: Simon J Hogg; Ricky W Johnstone; Jake Shortt
Source: check_circle
Monash University

Manipulation of B-cell responses with histone deacetylase inhibitors

Nature Communications
2015 | Journal article | Author
DOI: 10.1038/ncomms7838
SOURCE-WORK-ID:

3ca24800-d416-4d49-a3a1-0edd607bea84

EID:

2-s2.0-84928974764
Contributors: Michaela Waibel; Ailsa Jane Christiansen; Margaret Hibbs; Jake Shortt; Sarah Jones; Ian Simpson; Amanda Light; Kristy O'Donnell; Eric Francis Morand; David Tarlinton et al.
Source: check_circle
Monash University

Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers

Leukemia Research
2014 | Journal article | Author
DOI: 10.1016/j.leukres.2014.05.010
SOURCE-WORK-ID:

85fd9e87-9f0d-4132-8542-82b3e87a931a

EID:

2-s2.0-84904536509
Contributors: Jennifer A Westwood; Geoffrey M Matthews; Jake Shortt; David Faulkner; Hollie J Pegram; Connie P M Duong; Marta Chesi; Peter Leif Bergsagel; Leslie L Sharp; Richard D Huhn et al.
Source: check_circle
Monash University

From anecdote to targeted therapy: the curious case of thalidomide in multiple myeloma

Cancer Cell
2014 | Other | Author
DOI: 10.1016/j.ccr.2013.12.019
SOURCE-WORK-ID:

53ed13eb-b090-4812-b6d0-8ef9009e927a

EID:

2-s2.0-84892412407
Contributors: Jonathan D Licht; Jake Shortt; Ricky W Johnstone
Source: check_circle
Monash University

Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma

British Journal of Haematology
2014 | Journal article | Author
DOI: 10.1111/bjh.12922
SOURCE-WORK-ID:

1f49bed9-5884-4bf6-8578-0f6c1c178caf

EID:

2-s2.0-84907320063
Contributors: Pasquale Fedele; Kay-Weng Choy; James C G Doery; George Grigoriadis; Jake Shortt; Zhong Xian Lu
Source: check_circle
Monash University

N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?

Transfusion
2014 | Journal article | Author
DOI: 10.1111/trf.12787
SOURCE-WORK-ID:

3dabe19b-36a3-4117-a8e2-542a88d31852

EID:

2-s2.0-84908143754
Contributors: Jake Shortt; Stephen Opat; Erica Wood
Source: check_circle
Monash University

Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma

Current Opinion in Hematology
2014 | Journal article | Author
DOI: 10.1097/MOH.0000000000000045
SOURCE-WORK-ID:

6e2329b7-5608-4e41-a2fc-67d6a4549fc6

EID:

2-s2.0-84902258856
Contributors: Michaela Waibel; Gareth Peter Gregory; Jake Shortt; Ricky W Johnstone
Source: check_circle
Monash University

The drug vehicle and solvent N-Methylpyrrolidone is an immunomodulator and antimyeloma compound

Cell Reports
2014 | Journal article | Author
DOI: 10.1016/j.celrep.2014.04.008
SOURCE-WORK-ID:

703d5d4b-586b-44b0-91b1-ec8cb78ad788

EID:

2-s2.0-84901248465

WOSUID:

000336495700011

PMID: 24813887
Contributors: Jake Shortt; Andy K Hsu; Benjamin P Martin; Karen Doggett; Geoffrey Mark Matthews; Maria A Doyle; Jason Ellul; Tina E Jockel; Daniel M K Andrews; Simon J Hogg et al.
Source: check_circle
Monash University

ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura

New England Journal of Medicine
2013 | Journal article | Author
DOI: 10.1056/NEJMc1213206
SOURCE-WORK-ID:

125ee86e-89b2-41ae-8fea-0337fd259408

EID:

2-s2.0-84871810864
Contributors: Jake Shortt; Danielle H Oh; Stephen Opat
Source: check_circle
Monash University

AKT signalling is required for ribosomal RNA synthesis and progression of E-mu-Myc B-cell lymphoma in vivo

FEBS Journal
2013 | Journal article | Author
DOI: 10.1111/febs.12135
SOURCE-WORK-ID:

0e2b4ca7-88a6-425b-845e-6516464f1102

EID:

2-s2.0-84886095337
Contributors: Jennifer R Devlin; Katherine M Hannan; Pui Yee Ng; Megan Bywater; Jake Shortt; Carleen M Cullinane; Grant McArthur; Ricky W Johnstone; Ross Duncan Hannan; Richard Bruce Pearson
Source: check_circle
Monash University

An intact immune system is required for the anticancer activities of histone deacetylase inhibitors

Cancer Research
2013 | Journal article | Author
DOI: 10.1158/0008-5472.CAN-13-0890
SOURCE-WORK-ID:

26b97134-3b55-4457-992b-28e264ca8be1

EID:

2-s2.0-84891276397
Contributors: Alison C West; Stephen R Mattarollo; Jake Shortt; Leonie A Cluse; Ailsa Jane Christiansen; Mark J Smyth; Ricky W Johnstone
Source: check_circle
Monash University

Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas

Blood
2013 | Journal article | Author
DOI: 10.1182/blood-2012-08-446096
SOURCE-WORK-ID:

78498b8e-825b-4e63-8ba4-f13ae93f8db8

EID:

2-s2.0-84879437606
Contributors: Jake Shortt; Benjamin P Martin; Andrea Newbold; Katherine M Hannan; Jennifer R Devlin; Adele Baker; Rachael A Ralli; Carleen M Cullinane; Clemens A Schmitt; Maurice Reimann et al.
Source: check_circle
Monash University

FISH detection of PML-RARA fusion in ins(15;17) acute promyelocytic leukaemia depends on probe size

BioMed Research International
2013 | Journal article | Author
DOI: 10.1155/2013/164501
SOURCE-WORK-ID:

5b9a1f5a-a16a-46d7-8ecd-f3d2251c3d92

EID:

2-s2.0-84876560510
Contributors: Lynda J Campbell; Paul Oei; Ross Brookwell; Jake Shortt; Nicola Eaddy; Ashley Quan Ping Ng; Edward Chew; Peter J Browett
Source: check_circle
Monash University

Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner

Cell Cycle
2013 | Journal article | Author
DOI: 10.4161/cc.24805
SOURCE-WORK-ID:

32c48a07-dafb-4663-990b-3a5fd991b8e9

EID:

2-s2.0-84878568273
Contributors: Sue Haupt; Catherine Mitchell; Vincent Corneille; Jake Shortt; Stephen Fox; Pier Paolo Pandolfi; Mireia Castillo-Martin; Dennis M Bonal; Carlos Cordon-Cardo; Guillermina Lozano et al.
Source: check_circle
Monash University

Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma

Cell Death and Disease
2013 | Journal article | Author
DOI: 10.1038/cddis.2013.306
SOURCE-WORK-ID:

e3b674d6-5a78-493d-8810-0ea467dfd5d2

EID:

2-s2.0-84884996251
Contributors: Geoffrey Mark Matthews; Marcus Lefebure; Maria A Doyle; Jake Shortt; Jason Ellul; Marta Chesi; Kellie-Marie Banks; Eva Vidacs; David Faulkner; Peter Atadja et al.
Source: check_circle
Monash University

Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy

Oncogene
2013 | Journal article | Author
DOI: 10.1038/onc.2012.599
SOURCE-WORK-ID:

8f7325a9-d391-4e0b-81f3-32ab1f07dbcb

EID:

2-s2.0-84876571810
Contributors: Jake Shortt; Andy K Hsu; Ricky W Johnstone
Source: check_circle
Monash University

The mTORC1 inhibitor everolimus prevents and treats Emu-Myc lymphoma by restoring oncogene-induced senescence

Cancer Discovery
2013 | Journal article | Author
DOI: 10.1158/2159-8290.CD-12-0404
SOURCE-WORK-ID:

26ec3e1a-ab17-4db1-ac53-9c291ea78e1a

EID:

2-s2.0-84872857051
Contributors: Meaghan Wall; Gretchen Poortinga; Kym L Stanley; Ralph K Lindemann; Michael Bots; Christopher James Chan Chan; Megan Bywater; Kathryn M Kinross; Megan V Astle; Kelly Lee Waldeck et al.
Source: check_circle
Monash University

Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy

Blood
2012 | Journal article | Author
DOI: 10.1182/blood-2012-02-412783
SOURCE-WORK-ID:

22de1680-d714-4d13-bb14-6c502b17c811

EID:

2-s2.0-84864040412
Contributors: Marta Chesi; Geoffrey Mark Matthews; Victoria M Garbitt; Stephen E Palmer; Jake Shortt; Marcus Lefebure; A Keith Stewart; Ricky W Johnstone; Peter Leif Bergsagel
Source: check_circle
Monash University

E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis

Blood
2012 | Journal article | Author
DOI: 10.1182/blood-2011-10-387647
SOURCE-WORK-ID:

8f4e471d-94f2-4bd5-8a09-71255eca41ed

EID:

2-s2.0-84864495265
Contributors: Kamil Wolyniec; Jake Shortt; Elisa De Stanshina; Yaara Levav-Cohen; Osnat Alsheich-Bartok; Igla Louria-Hayon; Vincent Corneille; Beena Kumar; Simone J Woods; Stephen Opat et al.
Source: check_circle
Monash University

MDS with del(5q) and associated cKIT D816V positive mastocytosis

Pathology
2012 | Journal article | Author
DOI: 10.1097/PAT.0b013e3283559d03
SOURCE-WORK-ID:

c04e9c6d-20be-4ad8-bd41-cfdeb37fcf62

EID:

2-s2.0-84866953945
Contributors: Noel Chan; Shuh-Ying Tan; Stephen Opat; Jake Shortt
Source: check_circle
Monash University

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma

Blood
2012 | Journal article | Author
DOI: 10.1182/blood-2012-04-426643
SOURCE-WORK-ID:

c42e225b-5ba1-40da-b45b-6b2e02280308

EID:

2-s2.0-84867795406
Contributors: Stephen R Mattarollo; Alison C West; Kim Gertruda Marcella Steegh; Helene Duret; Christopher Paget; Benjamin P Martin; Geoffrey Mark Matthews; Jake Shortt; Marta Chesi; Peter Leif Bergsagel et al.
Source: check_circle
Monash University

Oncogenes in cell survival and cell death

Cold Spring Harbor Perspectives in Biology
2012 | Journal article | Author
DOI: 10.1101/cshperspect.a009829
SOURCE-WORK-ID:

84e84eae-d13a-42f7-91c9-0bdf7268022f

EID:

2-s2.0-84870747810
Contributors: Jake Shortt; Ricky W Johnstone
Source: check_circle
Monash University

Serum protein electrophoresis: A precautionary tale

Pathology
2012 | Journal article | Author
DOI: 10.1097/PAT.0b013e328353be32
SOURCE-WORK-ID:

7dcfb716-6583-407d-bffe-1e3d9277fe33

EID:

2-s2.0-84863695415
Contributors: George Grigoriadis; Jake Shortt; Hang Quach; Stephen Opat
Source: check_circle
Monash University

Plasmodium species co-infection as a cause of treatment failure

Travel Medicine and Infectious Disease
2011 | Journal article | Author
DOI: 10.1016/j.tmaid.2011.09.006
SOURCE-WORK-ID:

9d1a9bda-4e69-4699-8d2f-3eaaf6ba29a7

EID:

2-s2.0-82755194753
Contributors: Alison Smith; Justin T Denholm; Jake Shortt; Denis William Spelman
Source: check_circle
Monash University

Failure of eculizumab to correct paroxysmal cold hemoglobinuria

Annals of Hematology
2011-08 | Journal article | Author
DOI: 10.1007/s00277-010-1123-x
DOI: 10.1007/s00277-010-1123-x
SOURCE-WORK-ID:

c5b53905-2469-447c-8f7d-890273ce62b2

EID:

2-s2.0-79960234691

EID:

2-s2.0-79960234691

PMID: 21110191
Contributors: Gareth Peter Gregory; Stephen Opat; Hang Quach; Jake Shortt; Huyen Tran
Source: check_circle
Monash University

A retrospective study of the utility of desmopressin (1-deamino-8-D- arginine vasopressin) trials in the management of patients with von Willebrand disorder

International Journal of Laboratory Hematology
2010 | Journal article | Author
DOI: 10.1111/J.1751-553X.2008.01117.X
SOURCE-WORK-ID:

77d7a5b2-ed1a-4771-ae19-52ec0dccf023

EID:

2-s2.0-77249139828
Contributors: Jake Shortt; Stephen Opat; Malgorzata B Gorniak; Heather A Aumann; Margaret F Collecutt; Alison M Street
Source: check_circle
Monash University

Functional imaging in the age of targeted therapeutics for haematological cancers

ANZ Nuclear Medicine
2010 | Journal article | Author
SOURCE-WORK-ID:

a7a0e995-80f9-42ce-9f3c-ed52ffc9c14c

EID:

2-s2.0-77957244197
Contributors: Jake Shortt; Andrea Newbold; Ricky W Johnstone
Source: check_circle
Monash University

Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage

Transfusion
2009 | Journal article | Author
DOI: 10.1111/j.1537-2995.2009.02305.x
SOURCE-WORK-ID:

476db5aa-c999-457c-b2e7-11223e3bdeb8

EID:

2-s2.0-70449087460
Contributors: Jake Shortt; Mark N Polizzotto; Neil Waters; Marija Borosak; Martine Moran; Mary Comande; Alexandra Devine; Damien John Jolley; Erica Wood
Source: check_circle
Monash University

A 'dangerous' group O donor: Severe hemolysis in all recipients of organs from a donor with multiple red cell alloantibodies

American Journal of Transplantation
2008 | Journal article | Author
SOURCE-WORK-ID:

0c7f3363-32bf-4a60-a768-3ba845bf040f

EID:

2-s2.0-39649090261
Contributors: Jake Shortt; Glen Westall; D Roxby; J W Chen; Gregory I Snell; Mark N Polizzotto; G Magrin; Andrew I Webb; Alison M Street; M Borosak et al.
Source: check_circle
Monash University

A drop of vitriol: Microspherocytosis following sulphuric acid exposure

British Journal of Haematology
2008 | Journal article | Author
DOI: 10.1111/j.1365-2141.2007.06938.x
SOURCE-WORK-ID:

a221f671-c2a3-49f2-bd31-bee9c2421e15

EID:

2-s2.0-39749118256
Contributors: Mark N Polizzotto; Jake Shortt; Stephen Opat; Merrole Faye Cole-Sinclair
Source: check_circle
Monash University

Acute splenic sequestration complicating sickle cell disease

European Journal of Haematology
2008 | Journal article | Author
DOI: 10.1111/j.1600-0609.2008.01070.x
SOURCE-WORK-ID:

572abd4d-bfa8-4633-8054-c8dd50cffbff

EID:

2-s2.0-45449095027
Contributors: Mark N Polizzotto; Jake Shortt; Merrole Faye Cole-Sinclair
Source: check_circle
Monash University
Items per page:
Page 1 of 2
How many people are using ORCID?